Basics Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems. IPO Date: October 27, 2010 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $381.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.23% Avg Daily Range (30 D): $0.05 | 3.82% Avg Daily Range (90 D): $0.05 | 3.89% Institutional Daily Volume Avg Daily Volume: 2.58M Avg Daily Volume (30 D): 6.19M Avg Daily Volume (90 D): 7.87M Trade Size Avg Trade Size (Sh.): 191 Avg Trade Size (Sh.) (30 D): 500 Avg Trade Size (Sh.) (90 D): 563 Institutional Trades Total Inst.Trades: 4,318 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $1.39M Avg Inst. Trade (90 D): $1.2M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.4M Avg Closing Trade (30 D): $1.93M Avg Closing Trade (90 D): $1.47M Avg Closing Volume: 339.48K     News Aug 6, 2025 @ 1:00 PM PacBio to Present at Upcoming Investor Conferences... Source: Pacbio Jun 21, 2025 @ 12:00 PM Long Read Sequencing Market Projected to Reach USD... Source: Sns Insider May 14, 2025 @ 8:30 AM Metagenomics Market Size, Share, Forecast & Trends... Source: Researchandmarkets.Com May 12, 2025 @ 2:56 PM PacBio Board Independent Investigation Concludes A... Source: N/A Feb 15, 2025 @ 4:09 AM PacBio Grants Equity Incentive Award to New Employ... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.77 $-.14 $-1.44 Diluted EPS $-2.23 $-.14 $-1.44 Revenue $ 156.11M $ 39.77M $ 37.15M Gross Profit $ 33.38M $ 14.68M $ -1.37M Net Income / Loss $ -526.36M $ -41.93M $ -426.08M Operating Income / Loss $ -690.89M $ -44.85M $ -428.93M Cost of Revenue $ 122.74M $ 25.08M $ 38.52M Net Cash Flow $ -45.16M $ -4.09M $ 3.14M PE Ratio